Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination

Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination

At the end of 2020, population-based vaccination programs with new generation mRNA-based vaccines began almost all over the world. The aim of the study was to evaluate the titer of anti-SARS-CoV-2 IgG antibodies against the S1 subunit of the virus’s spike protein as a marker of the humoral response...

Full description

Bibliographic Details
Main Authors: Andrzej Tretyn, Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz-Tretyn, Dorota Sandomierz, Joanna Dejewska, Karolina Ciechanowska, Aleksander Jarkiewicz-Tretyn, Wojciech Koper, Krzysztof Pałgan
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cells
Subjects:
COVID-19
Comirnaty
humoral response
cellular response
mRNA vaccine
spike protein
Online Access:https://www.mdpi.com/2073-4409/10/8/1952

Similar Items

Similar Items